Skip to content

Mental Health and Transgender (MenTra): integrating mental health services into primary care settings; a mixed-methods study of the mhGAP intervention

Mental Health and Transgender (MenTra): a feasibility trial of integrating mental health services into primary care settings using the mhGAP intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12146586
Enrollment
144
Registered
2025-10-08
Start date
2026-03-19
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression and anxiety among transgender individuals Mental and Behavioural Disorders

Interventions

Intervention: The intervention comprises the integration of WHO’s mental health Gap Action Program (mhGAP) protocols into primary care practice (GP Clinics). General practitioners will be trained to i
(b) a handbook to be used by the GPs in which sessions details along with character examples to demonstrate how each intervention strategy can be implemented by clients in their life
(c) flyers to aid the intervention

Sponsors

Health Research Institute, National Institute for Health Pakistan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults (aged =18 years) 2. Self-identifying as transgender 3. Residing in district Peshawar 4. Possessing a valid national identity card 5. Positive screen for both depression and anxiety, defined as scores =3 on the Patient Health Questionnaire-2 (PHQ-2) and Generalized Anxiety Disorder-2 (GAD-2)

Exclusion criteria

Exclusion criteria: Individuals already engaged in ongoing psychiatric or psychological treatment at study onset will be excluded to avoid confounding treatment effects

Design outcomes

Primary

MeasureTime frame
1. Depressive symptoms measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline (pre-intervention), 2-month follow-up, and 4-month follow-up 2. Anxiety symptoms measured using the Generalized Anxiety Disorder-7 (GAD-7) at baseline (pre-intervention), 2-month follow-up, and 4-month follow-up

Secondary

MeasureTime frame
Feasibility and process outcomes: 1. Recruitment rate: number and proportion of eligible participants who consent and enroll, measured at baseline. 2. Retention rate: number and proportion of participants completing both follow-up assessments at 2 and 4 months. 3. Treatment adherence: number and proportion of participants attending all three scheduled mhGAP-based CBT sessions. Participants missing no more than one session are classified as “adherent”; others as “non-adherent.” Measured at 4 months post-intervention, based on GP session logs.

Countries

Pakistan

Contacts

Public ContactSaima;Abdul Jalil Aleem;Khan

;

saima.aleem@kmu.edu.pk;Jalilkhan@kmu.edu.pk+92 (0)3355070760;+92 (0)336 9613278

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026